Results 281 to 290 of about 18,323,172 (295)

Modified IL-4 mutein receptor antagonists

2010
PAN CLARK, ROCZNIAK STEVE, GREVE JEFFREY MICHAEL, YUNG STEPHANIE L, LONGPHRE MALINDA, WONG TERESA MO-FUN, TOMKINSON ADRIAN, BOISVERT DAVID, BURMEISTER-GETZ ELISE, DELARIA KATHY   +9 more
openaire   +2 more sources

Muscarinic acetylcholine receptors: novel opportunities for drug development

Nature Reviews Drug Discovery, 2014
Brian Kobilka, Patrick M. Sexton, Andrew C Kruse   +2 more
exaly  

Targeting proteinase-activated receptors: therapeutic potential and challenges

Nature Reviews Drug Discovery, 2012
Kathryn DeFea, Rithwik Ramachandran, Morley D Hollenberg   +2 more
exaly  

Teaching old receptors new tricks: biasing seven-transmembrane receptors

Nature Reviews Drug Discovery, 2010
Keshava Rajagopal, Sudarshan Rajagopal
exaly  

Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes

Nature Reviews Drug Discovery, 2011
Uwe Rudolph
exaly  

REV-ERB and ROR nuclear receptors as drug targets

Nature Reviews Drug Discovery, 2014
Douglas J Kojetin, Thomas Burris
exaly  

Personalizing therapies over the course of hormone receptor-positive/HER2-negative metastatic breast cancer.

Ca-A Cancer Journal for Clinicians
Carlos H Barcenas, Suzanne A W Fuqua, Senthil Damodaran   +2 more
exaly  

Pursuit of precision oncology in the treatment of metastatic hormone receptor–positive breast cancer: Making strides or barely moving?

Ca-A Cancer Journal for Clinicians
Ajay Dhakal, Ilana Schlam
exaly  

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

Ca-A Cancer Journal for Clinicians
Andrea Gallamini, Philipp Lohmann, Malik E. Juweid   +2 more
exaly  

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Ca-A Cancer Journal for Clinicians
Kaushal Parikh, Jair Bar, Claudio de Vito   +2 more
exaly